NASDAQ:CYCN

Cyclerion Therapeuticsinc Stock Predictions

etoro logo Buy CYCN
*Your capital is at risk
$3.00
-0.0200 (-0.662%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

CYCN Prediction Chart

CYCN Predictions History

Latest community submissions for CYCN.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Sep 7, 2021 $3.15 -95.03% $3.17 V 99.37% 3
JS JS Pro
May 14, 2021 $2.81 -95.22% $2.94 V 95.58% 0
May 14, 2021 Bullish $2.94 X 0
JS JS Pro
May 10, 2021 $2.81 -94.87% $2.74 X 97.45% 0
kazhiryu187 kazhiryu187 @kazhiryu187.236779
May 10, 2021 $2.90 -94.71% $2.74 X 94.16% 0
Alan Alan Pro @Alan.115878
Jun 22, 2020 $5.15 -95.07% $5.22 V 98.66% 2
JS JS Pro
May 11, 2020 $4.21 -95.26% $4.44 X 94.82% 1
Alan Alan Pro @Alan.115878
May 11, 2020 $4.25 -95.21% $4.44 X 95.72% 1
Sep 18, 2019 $12.46 -95.43% $13.63 X 91.42% 1
Sep 18, 2019 $12.00 -95.60% $13.63 V 88.04% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CYCN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYCLERION THERAPEUTICSINC.
Cyclerion TherapeuticsInc
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE